natgillin/translations-raw huggingface dataset:
“Sertraline is indicated for the treatment of obsessive compulsive disorder (OCD) in adults and paediatric patients aged 6-17 years.” 
„Sertralin je indiciran za zdravljenje obsesivno kompulzivne motnje (OKM) pri odraslih in pediatričnih bolnikih, starih od 6 do 17 let“.
Sertraline concentrate for oral solution is contraindicated with the use of disulfiram due to the alcohol content of the oral concentrate (see sections 4.4 and 4.5). 
Koncentrat za peroralno raztopino sertralina je kontraindiciran med uporabo disulfirama, ker raztopina vsebuje alkohol (glejte poglavji 4.4 in 4.5).
Withdrawal symptoms seen on discontinuation of sertraline Abrupt discontinuation should be avoided. 
Odtegnitveni simptomi, ki se pojavijo po prenehanju zdravljenja s sertralinom Nenadnemu prenehanju zdravljenja s sertralinom se je potrebno izogniti.
ANNEX II SCIENTIFIC CONCLUSIONS AND GROUNDS FOR THE AMENDMENT OF THE SUMMARIES OF PRODUCT CHARACTERISTICS, LABELLING AND PACKAGE LEAFLET PRESENTED BY THE EMEA 
DODATEK II ZNANSTVENI ZAKLJUČKI IN PODLAGA ZA DOPOLNILO POVZETKA GLAVNIH ZNAČILNOSTI ZDRAVILA, OZNAČEVANJA IN NAVODILA ZA UPORABO, KI JIH JE PREDSTAVILA EVROPSKA AGENCIJA ZA ZDRAVILA
When co-administering sertraline with lithium, patients should be appropriately monitored. 
Med sočasno uporabo sertralina z zdravili, kakršno je litij, je bolnike treba ustrezno nadzorovati.
Thoughts of suicide and worsening of your depression or anxiety disorder: If you are depressed and/or have anxiety disorders you can sometimes have thoughts of harming or killing yourself. 
Misli na samomor in poslabšanje depresije ali anksiozne motnje Pri bolnikih z depresijo in/ali anksiozno motnjo se občasno lahko pojavijo misli na samopoškodovanje ali samomor.
However, a substantial amount of data did not reveal evidence of induction of congenital malformations by sertraline. 
Obsežni podatki niso razkrili dokazov, da bi sertralin izzval prirojene malformacije.
Withdrawal symptoms seen on discontinuation of sertraline treatment Withdrawal symptoms when treatment is discontinued are common, particularly if discontinuation is abrupt (see section 4.8). 
Odtegnitveni simptomi po prenehanju zdravljenja s sertralinom Po prenehanju zdravljenja so odtegnitveni simptomi pogosti, zlasti če je prenehanje nenadno (glejte poglavje 4.8).
Very common side effects (occurs in more than 1 out of 10 patients): Insomnia, dizziness, sleepiness, headache, diarrhoea, feeling sick, dry mouth, ejaculation failure, fatigue. 
Zelo pogosti neželeni učinki (pojavijo se pri več kot 1 od 10 bolnikov): Nespečnost, omotica, zaspanost, glavobol, driska, siljenje na bruhanje, suhost ust, nezmožnost ejakulacije, utrujenost.
If you accidentally take too much Zoloft contact your doctor at once or go to the nearest hospital casualty department. 
Če ste vzeli večji odmerek zdravila Zoloft, kot bi smeli Če pomotoma vzamete preveč zdravila Zoloft, se takoj obrnite na svojega zdravnika, ali pojdite do najbližje nujne medicinske pomoči.
The undesirable effects profile commonly observed in double-blind, placebo-controlled studies in patients with OCD, panic disorder, PTSD and social anxiety disorder was similar to that observed in clinical trials in patients with depression. 
Profil neželenih učinkov, pogosto opažen v dvojno slepih, s placebom nadzorovanih študijah pri bolnikih z OKM, panično motnjo, PTSM in socialno anksiozno motnjo, je bil podoben kot v kliničnih preskušanjih pri bolnikih z depresijo.
After a one week single blind placebo lead-in, patients were randomly assigned to twelve weeks of flexible dose treatment with either sertraline or placebo. 
Po enotedenskem enojno slepem obdobju uvajanja so bolnike slučajno razvrstili na dvanajst tednov zdravljenja s prilagodljivim odmerkom sertralina ali placebom.
“Sertraline is indicated for the treatment of post traumatic stress disorder (PTSD)”, 
„Sertralin je indiciran za zdravljenje posttravmatske stresne motnje (PTSM)“,
• Herbal medicine containing St. John's Wort (Hypericum perforatum). 
• Zdravila rastlinskega izvora, ki vsebujejo šentjanževko (Hypericum perforatum).
• Medicines to treat diabetes (tolbutamide). 
• Zdravila za zdravljenje sladkorne bolezni (tolbutamid)
Section 4.1 - Indications: Obsessive Compulsive Disorder (OCD) (In adults) 
Poglavje 4.1 - Indikacije: Obsesivno kompulzivna motnja (OKM) (pri odraslih)
• Medicines to treat migraines (e.g. sumatriptan). 
• Zdravila za zdravljenje migrene (npr. sumatriptan).
Also reported were signs and symptoms associated with serotonin syndrome: In some cases associated with concomitant use of serotonergic drugs that included agitation, confusion, diaphoresis, diarrhoea, fever, hypertension, rigidity and tachycardia. 
Opisani so bili tudi znaki in simptomi, povezani s serotoninskim sindromom, v nekaterih primerih med sočasno uporabo serotoninergičnih zdravil; vključevali so agitiranost, zmedenost, znojenje, drisko, zvišano telesno temperaturo, hipertenzijo, rigidnost in tahikardijo.
Use in elderly Elderly should be dosed carefully, as elderly may be more at risk for hyponatraemia (see section 4.4). 
Pri starejših bolnikih je treba zdravilo odmerjati previdno, kajti tveganje za hiponatriemijo je lahko pri njih večje (glejte poglavje 4.4).
In most of the cases, the recommended dose in prevention of recurrence of MDE is the same as the one used during current episode. 
Priporočeni odmerek za preprečevanje recidivov hudih depresivnih epizod je večinoma enak tistemu, ki ga bolnik dobiva med trenutno epizodo.
• Liver disease; your doctor may decide that you should have a lower dose of Zoloft. 
• Obolenje jeter; zdravnik se lahko odloči za zmanjšanje odmerka.
Therefore sertraline should be used with caution in patients with a history of mania/hypomania. 
Zato morate sertralin pri bolnikih z anamnezo manije ali hipomanije uporabljati previdno.
Hypercholesterolaem ia, Hypoglycaemia 
hiperholesterolemija, hipoglikemija hiponatriemija
The maximum recommended dose is (10 ml) 200 mg/day. 
Maksimalni priporočeni odmerek je (10 ml) 200 mg/dan.
Anorexia, Increased Appetite* 
Presnovne in prehranske motnje anoreksija, povečan apetit*
• Sedatives (diazepam). 
• Pomirjevala (imenujemo jih tudi sedativi; diazepam)
Children (6-12 years old) were initially started on a 25 mg dose. 
Otroci (6-12 let) so začeli z 25 mg odmerki.
Use in nursing mothers is not recommended unless, in the judgment of the physician, the benefit outweighs the risk. 
Uporaba pri doječih materah ni priporočljiva, razen če koristi po zdravnikovi presoji odtehtajo tveganja.
In a placebo-controlled trial in normal volunteers, the co-administration of sertraline with lithium did not significantly alter lithium pharmacokinetics, but did result in an increase in tremor relative to placebo, indicating a possible pharmacodynamic interaction. 
V preskušanju, nadzorovanem s placebom, pri zdravih prostovoljcih sočasna uporaba sertralina in litija ni pomembno spremenila farmakokinetike litija, je pa v primerjavi s placebom zvečala tremor, kar nakazuje možno farmakodinamično medsebojno delovanje.
Take special care with Zoloft: 
Bodite posebno pozorni pri uporabi zdravila Zoloft:
“Sertraline is indicated for the treatment of social anxiety disorder”. 
„Sertralin je indiciran za zdravljenje socialne anksiozne motnje“.
“Sertraline is indicated for the treatment of panic disorder, with or without agoraphobia”. 
„Sertralin je indiciran za zdravljenje panične motnje z agarafobijo ali brez nje“.
With the condition that the following text is inserted in section 5.1 of the SPC: 
Pod pogojem, da se v poglavje 5.1 povzetka glavnih značilnosti zdravila vključi naslednje besedilo:
Caution is advised in patients taking SSRIs, particularly in concomitant use with drugs known to affect platelet function (e.g. anticoagulants, atypical antipsychotics and phenothiazines, most tricyclic antidepressants, acetylsalicylic acid and non-steroidal anti-inflammatory drugs (NSAIDs)) as well as in patients with a history of bleeding disorders (see section 4.5). 
Previdnost je potrebna med sočasno uporabo SSRI in zdravil, ki vplivajo na delovanje trombocitov (npr. antikoagulanti, atipični antipsihotiki in fenotiazini, večina tricikličnih antidepresivov, acetilsalicilna kislina in nesteroidna protivnetna zdravila (NSAIDs)), kakor tudi pri bolnikih z motnjami strjevanja krvi (glejte poglavje 4.5).
The four short-term placebo controlled studies were conducted in patients with PTSD and consisted of 1/2 weeks single-blind placebo run-in, followed by 12 week double-blind treatment. 
Pri bolnikih s PTSM so bile izvedene štiri kratkoročne, s placebom kontrolirane študije, ki so obsegale poltedensko enojno slepo uvajalno fazo s placebom, kateremu je sledilo 12-tedensko dvojno slepo zdravljenje.
Sertraline should not usually be used in children and adolescents less than 18 years old, except for patients with Obsessive Compulsive Disorder. 
Zdravila Zoloft se običajno ne sme uporabljati za zdravljenje otrok in mladostnikov, mlajših od 18 let, razen bolnikov z obsesivno kompulzivno motnjo.
Glycerol: at high doses, can cause headache, abdominal pain and diarrhoea. 
Glicerol: pri visokih odmerkih lahko povzroči glavobol, bolečino v trebuhu in drisko.
Also, the long-term safety of Zoloft in regard to growth, maturation and cognitive and behavioural development in this age group has not yet been demonstrated. 
Poleg tega za zdravilo Zoloft v tej starostni skupini še niso na dolgi rok dokazani varnostni učinki v zvezi z rastjo, odraščanjem ter kognitivnim in vedenjskim razvojem.
These reactions have included tremor, myoclonus, diaphoresis, nausea, vomiting, flushing, dizziness, and hyperthermia with features resembling neuroleptic malignant syndrome, seizures, and death. 
Med temi učinki so bili tremor, mioklonus, znojenje, navzea, bruhanje, zardevanje, omotica in hipertermija z značilnostmi, podobnimi malignemu nevroleptičnemu sindromu, konvulzije in smrt.
The 25 mg regimen and the 50 mg regimen were equally tolerated. 
Bolniki so enako dobro prenašali režim s 25 mg in 50 mg odmerki.
One single study was submitted in support of the paediatric indication, a 12 week randomised double blind study with a sertraline and a placebo arm. 
V podporo indikaciji v pediatriji je bila predložena ena sama študija, in sicer 12-tedenska randomizirana, dvojno slepa študija s krakom s sertralinom in placebom.
• If you start to get feelings of restlessness and not be able to sit or stand still after you start to take Zoloft. 
• Če se vam po zaužitju zdravila Zoloft pojavijo občutki nemira in ne morete sedeti ali stati pri miru.
Uncommon (≥1/1000 to 
Občasni (≥ 1/1000 do
The MAH submitted a revised study synopsis, now including a sertraline-unexposed control group and following the evaluation of this synopsis, the study proposal was supported. 
Imetnik dovoljenja za promet z zdravilom je predložil popravljen oris študije, v katero je bila sedaj vključena kontrolna skupina, ki ni bila zdravljena s sertralinom, po vrednotenju pa je bil predlog študije podprt.
There have been rare post-marketing reports describing patients with weakness, hyperreflexia, incoordination, confusion, anxiety and agitation following the use of sertraline and sumatriptan. 
Nekaj redkih poročil iz obdobja trženja je opisovalo bolnike, pri katerih so se po uporabi sertralina in sumatriptana pojavile šibkost, hiperrefleksija, nekoordiniranost, zmedenost, anksioznost in agitiranost.
Frequency of adverse reactions observed from placebo-controlled clinical trials in depression, OCD, panic disorder, PTSD and social anxiety disorder. 
Pogostnost neželenih učinkov, zabeležena v kliničnih preskušanjih, nadzorovanih s placebom, pri depresiji, OKM, panični motnji, PTSM in socialni anksiozni motnji.
A statistically significantly lower relapse rate was observed for patients taking sertraline compared to those on placebo. 
Pri bolnikih, ki so jemali sertralin so ugotovili statistično manjši delež relapsov v primerjavi z bolniki na placebu.
The following side effects were seen in clinical trials in adults. 
V kliničnih preskušanjih pri odraslih so opazili naslednje neželene učinke:
Deaths have been reported involving overdoses of sertraline, primarily in combination with other drugs and/or alcohol. 
Opisana so prevelika odmerjanja samega sertralina do 13,5 g. Poročali pa so o smrtnih primerih s prevelikimi odmerki sertralina v kombinaciji z drugimi zdravili in/ali alkoholom.
Rare side effects (occurs in between 1 and 10 out of 10.000 patients): 
Redki neželeni učinki (pojavijo se pri več kot 1 do 10 od 10.000 bolnikov):
The use of sertraline has been linked to akathisia (a distressing restlessness and need to move, often being unable to sit or stand still). 
Uporaba sertralina je bila povezana z akatizijo (stanje motorične nemirnosti, potreba po gibanju in nezmožnost stati ali sedeti pri miru).
Continued treatment in panic disorder and OCD should be evaluated regularly, as relapse prevention has not been shown for these disorders. 
Nadaljnje zdravljenje pri panični motnji in obsesivno-kompulzivni motnji je treba redno kontrolirati, kajti pri teh motnjah preprečitev ponovitve ni dokazana.
Generally these events are mild to moderate and are self-limiting; however, in some patients they may be severe and/or prolonged. 
Odtegnitvene reakcije so bile večinoma blage in so izzvenele same, vendar pa so bile pri nekaterih bolnikih tudi resne in/ali dolgotrajnejše.
• Medicines to treat mental disorders (pimozide). 
• Zdravila za zdravljenje duševnih motenj (pimozid).
This dosage regimen has been shown to reduce the frequency of early treatment emergent side effects characteristic of panic disorder. 
Ta shema dokazano zmanjša pogostnost neželenih učinkov, ki so značilni za panično motnjo in se pojavijo zgodaj med zdravljenjem.
Obsessive compulsive disorder (OCD) in adults and paediatric patients aged 6-17 years. 
Obsesivno-kompulzivne motnje (OKM) pri odraslih in pediatričnih bolnikih, starih od 6 do 17 let.
The CHMP considered that because no placebo was used, it is difficult to put the observed adverse events into perspective. 
CHMP je menil, da je opažene neželene učinke, ker ni bilo kontrole s placebom, težko ovrednotiti.
Sertraline does not function as a positive reinforcer in rhesus monkeys trained to self administer cocaine, nor does it substitute as a discriminative stimulus for either d-amphetamine or pentobarbital in rhesus monkeys. 
Pri opicah rhesus, ki so bile naučene, da si same dajejo kokain, sertralin ni deloval kot pozitiven ojačevalec; poleg tega pri opicah rhesus tudi ni bil nadomestilo diskriminativnega stimulusa za Damfetamin ali pentobarbital.
Table 1: Adverse Reactions 
Preglednica 1: Neželeni učinki
The daily dose may be increased in (2.5 ml) 50 mg increments and at intervals of at least one week over a period of weeks. 
Dnevni odmerek je mogoče povečevati po 50 mg (2,5 ml) v presledkih vsaj enega tedna v obdobju nekaj tednov.
A lower or less frequent dose should be used in patients with hepatic impairment (see section 4.4). 
Pri bolnikih z okvaro jeter je treba uporabiti manjši odmerek ali redkejše odmerjanje (glejte poglavje 4.4).
If you have been told by your doctor that you have intolerance to some sugars contact your doctor before taking this medicinal product. 
Pomembne informacije o nekaterih sestavinah zdravila Zoloft Če vam je zdravnik povedal, da imate intoleranco za nekatere sladkorje, se z njim posvetujte, preden vzamete to zdravilo.
No interaction of sertraline 200 mg daily was observed with digoxin. 
Med uporabo digoksina niso opažali medsebojnega delovanja s sertralinom v odmerku 200 mg na dan.
Butylhydroxytoluene: can cause irritation of eyes, skin and mucous membranes. 
Butilhidroksitoluen: lahko povzroči draženje oči, kože in sluznic.
• Social anxiety disorder (in adults). 
• Socialne anksiozne motnje (pri odraslih).
• If you are taking or have taken medicines called monoamine oxidase inhibitors (MAOIs such as selegiline, moclobemide) or MAOI like drugs (such as linezolid). 
• Če jemljete oziroma ste v zadnjih dveh tednih jemali katero od zdravil, imenovanih zaviralci monoaminooksidaze (MAOI), npr. selegilin ali moklobemid oziroma zaviralcem monoaminooksidaze podobna zdravila, npr. linezolid.
Further information. 
DODATNE INFORMACIJE
Post traumatic stress disorder (PTSD) 
Posttravmatske stresne motnje (PTSM).
Regarding safety, the incidence of AEs in the PTSD dossier is within the range reported in studies for other indications and SAEs were not considered to be related to the study medication. 
Glede varnosti je pogostost neželenih učinkov v dokumentaciji za PTSM primerljiva s študijami za druge indikacije, prav tako ni bilo ocenjeno, da bi bili resni neželeni učinki povezani s proučevanim zdravilom.
- the scope of the referral was the harmonisation of the Summaries of Products Characteristics, labelling and package leaflet. 
- namen napotitve je bil uskladitev povzetka glavnih značilnosti zdravila, označevanja in navodila za uporabo,
Dose changes should be made in steps of 50 mg at intervals of at least one week, up to a maximum of 200 mg/day. 
Najkrajši presledek med spremembami odmerka mora biti vsaj en teden, odmerek pa se lahko v korakih po 50 mg zveča do največ 200 mg/dan.
Uncommon side effects (occurs in between 1 and 10 out of 1.000 patients): 
Občasni neželeni učinki (pojavijo se pri več kot 1 do 10 od 1.000 bolnikov):
Adolescents aged 13 to 17: the recommended starting dose is (2.5 ml) 50 mg daily. 
Mladostniki 13-17 let: priporočeni začetni odmerek je (2,5 ml) 50 mg na dan.
Age 6-12 years: Initially 25 mg once daily. 
Starost 6 - 12 let: začetni odmerek - 25 mg enkrat na dan.
It is characterised by feelings of intense anxiety or distress in social situations (for example: talking to strangers, speaking in front of groups of people, eating or drinking in front of others or worrying that you might behave in an embarrassing manner). 
govorjenje pred skupino ljudi, uživanje hrane in pijače pred drugimi ali skrb pred osramotitvijo zaradi neprimernega vedenja).
Periorbital Oedema*, Purpura*, Alopecia*, Cold Sweat, Dry skin, Urticuria* 
Bolezni kože in podkožja izpuščaj*, hiperhidroza periorbitalni edemi*, purpura*, alopecija*, hladno znojenje, suha koža, urtikarija*
† One case of neoplasm was reported in one patient receiving sertraline compared with no cases in the placebo arm. * these adverse reactions also occurred in postmarketing experience ** the denominator uses the number of patients in that sex group-combined: sertraline (1118 males, 1424 females) placebo (926 males, 1219 females) 
** Imenovalec upošteva število bolnikov v tisti skupini po spolu kombinirano: sertralin (1118 moških, 1424 žensk) placebo (926 moških, 1219 žensk)
“Subsequent doses may be increased in case of less than desired response in 50 mg increments over a period of some weeks, as needed. 
„V primeru šibkejšega odziva od želenega se lahko nadaljnji odmerki po potrebi povečajo, in sicer s povečanjem za 50 mg v obdobju nekaj tednov.
Sertraline should only be used in women during lactation, if the doctor considers that the benefit for the mother exceeds any possible risk to the baby. 
Doječe matere smejo sertralin jemati le, če zdravnik presodi, da je korist za mater večja od morebitnega tveganja za otroka.
Food does not significantly change the bioavailability of sertraline concentrate for oral solution. 
Hrana ne povzroči pomembne spremembe biološke uporabnosti koncentrata za peroralno raztopino sertralina.
Common side effects (occurs in between 1 and 10 out of 100 patients): 
Pogosti neželeni učinki (pojavijo se pri več kot 1 do 10 od 100 bolnikov):
Chronic dosing with sertraline 50 mg daily showed moderate elevation (mean 23%-37%) of steady-state desipramine plasma levels (a marker of CYP 2D6 isozyme activity). 
Med kronično uporabo 50 mg sertralina na dan se je koncentracija dezipramina v plazmi (ki označuje aktivnost izoencima CYP 2D6) v stanju dinamičnega ravnovesja zmerno povečala (povprečno od 23 do 37 %).
SSRIs or SNRIs including sertraline have been associated with cases of clinically significant hyponatraemia in elderly patients, who may be at greater risk for this adverse event (see section 4.4). 
Uporabo SSRI ali SNRI, vključno s sertralinom, so pri starejših bolnikih spremljali primeri klinično pomembne hiponatriemije; starejše bolnike ta neželeni učinek morda bolj ogroža (glejte poglavje 4.4).
Sertraline is extensively metabolised by the liver. 
Sertralin se izdatno presnovi v jetrih.
Withdrawal symptoms seen on discontinuation of sertraline treatment Discontinuation of sertraline (particularly when abrupt) commonly leads to withdrawal symptoms. 
Odtegnitveni simptomi, ki se pojavijo po prenehanju zdravljenja s sertralinom Po prekinitvi zdravljenja (predvsem pri nenadni) se lahko pojavijo odtegnitvene reakcije.
Vasodilation Procedure 
POSTOPEK UPORABE Peroralna uporaba
If you stop treatment with sertraline, you must wait until at least one week before you start treatment with a MAOI. 
Če končate zdravljenje s sertralinom morate počakati najmanj 1 teden preden začnete zdravljenje z zaviralci monoaminooksidaze (MAOI).
PTSD is a condition that can occur after a very emotionally traumatic experience, and has some symptoms that are similar to depression and anxiety. 
Posttravmatska stresna motnja (PTSM) je zapoznel oziroma podaljšan odziv na stresen, izjemno ogrožajoč ali poguben dogodek, ki ima nekatere simptome podobne depresiji in tesnobnosti.
Rare (≥1/10000 to 
Redki (≥ 1/10000 do
Biotransformation Sertraline undergoes extensive first-pass hepatic metabolism. 
Presnova Sertralin je podvržen znatni presnovi prvega prehoda v jetrih.
Electroconvulsive therapy 
Elektrokonvulzivno zdravljenje
Unscrew the cap on the bottle by pushing down hard on the cap while turning the cap to the left (counter clockwise). 
Odvijte pokrovček s stekleničke tako, da ga močno pritisnete navzdol in ga hkrati zasučete v levo (v nasprotno smer urnega kazalca).
• If you are taking another medicine called Pimozide (an antipsychotic medicine). 
• Če jemljete pimozid (zdravilo za zdravljenje duševnih motenj)
The submitted results showed that the improvement on the primary outcome variable was statistically significantly greater in the sertraline versus the placebo arm. 
Predloženi rezultati dokazujejo, da je bilo izboljšanje glavnega pokazatelja pri kraku s sertralinom bistveno večje v primerjavi s krakom s placebom.
The clinical programme for the indication social anxiety disorder consisted of two short term double blind, randomized, placebo controlled clinical trials and two long term efficacy and safety studies. 
Klinični program za indikacijo socialna anksiozna motnja je bil sestavljen iz dveh kratkoročnih, dvojno slepih, randomiziranih, s placebom kontroliranih kliničnih preskušanj in dveh dolgoročnih študij učinkovitosti in varnosti.
Contractions Involuntary*, Coordination Abnormal, Hyperkinesia, Amnesia, Hypoaesthesia* , Speech Disorder, Dizziness Postural, Migraine* 
konvulzije*, nehotno krčenje mišic*, nenormalna koordinacija, hiperkinezija, amnezija, hipestezija*, motnja govora, posturalna omotica, migrena*
This medicinal product contains butylhydroxytoluene which can cause irritation of eyes, skin and mucous membranes. 
Zdravilo vsebuje butilhidroksitoluen, ki lahko draži oči, kožo in sluznice.
If you suddenly stop taking this medicine you may experience side effects such as dizziness, numbness, sleep disturbances, agitation or anxiety, headaches, feeling sick, being sick and shaking. 
Če zdravilo nehate jemati nenadoma, se vam lahko pojavijo neželeni učinki, npr. omotica, odrevenelost, motnje spanja, vznemirjenost ali tesnobnost, glavoboli, slabost, siljenje na bruhanje in tresenje.
• Medicines to treat epilepsy (phenytoin). 
• Zdravila za zdravljenje epilepsije (feniotin)
Therefore, sertraline concentrate for oral solution should not be used in combination with disulfiram or within 14 days of discontinuing treatment with disulfiram (see sections 4.3 and 4.4). 
Zato se sertralin koncentrat za peroralno raztopino ne sme uporabljati sočasno z disulfiramom oziroma še dva tedna po prenehanju jemanja disulfirama (glejte poglavje 4.3 in 4.4).